wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Week 4 CARDIO

Total questions: 150

Worksheet time: 1hrs 15mins

Name
Class
Date
1.

In a dominant left coronary system, which vessels typically originate from the left circumflex artery (LCX)?

a)

Posterior descending artery and postero-lateral branches

b)

Left anterior descending and septal perforators

c)

Right coronary artery and conus branch

d)

Obtuse marginal and sinoatrial nodal artery

2.

Which statement best describes a balanced coronary system?

a)

Both PDA and postero-lateral branches arise from the RCA

b)

PDA arises from the RCA while LV postero-lateral branches arise from the LCX

c)

Both PDA and postero-lateral branches arise from the LCX

d)

PDA arises from the LAD while postero-lateral branches arise from the RCA

3.

Coronary perfusion predominantly occurs during which phase of the cardiac cycle?

a)

Early systole

b)

Late systole

c)

Diastolic phase

d)

Isovolumic contraction

4.

Which factor directly impedes coronary blood flow according to the material?

a)

Increased hemoglobin concentration

b)

Myocardial contraction

c)

Lower heart rate

d)

Epicardial location in grooves

5.

In the supply vs demand framework, vigorous exercise primarily requires what change to meet myocardial oxygen demand?

a)

Decreased coronary artery flow

b)

Increased delivery of oxygen to the myocardium

c)

Reduced wall stress

d)

Lower heart rate

6.

Which intervention listed is specifically noted to slow heart rate in this material?

a)

Nitrates and dihydropyridine calcium channel blockers

b)

Beta blockers and non-dihydropyridine calcium channel blockers

c)

ACE inhibitors and statins

d)

Aspirin and anticoagulants

7.

During the cardiac cycle, which phase varies with heart rate according to the material?

a)

Systole varies; diastole remains constant

b)

Both systole and diastole vary equally

c)

Diastole varies; systole remains constant

d)

Neither phase varies with heart rate

8.

Which sequence best represents the developmental progression of atherosclerotic lesions described in the pathophysiology slide?

a)

Fibrous plaque → fatty streak → foam cells → complicated lesion

b)

Foam cells → fatty streak → intermediate lesion/atheroma → fibrous plaque → complicated lesion/rupture

c)

Fatty streak → foam cells → fibrous plaque → thrombus → normal artery

d)

Complicated lesion → intermediate lesion → foam cells → fibrous plaque

9.

Which statement best defines the principle of ischemic heart disease in Coronary Artery Disease (CAD)?

a)

Imbalance between myocardial oxygen supply and demand due to atherosclerotic coronary disease

b)

Excessive myocardial oxygen supply caused by vasospasm only

c)

Normal oxygen balance with transient conduction delays

d)

Reduced systemic oxygen content from lung disease only

10.

What is the major underlying cause of Coronary Artery Disease according to the material?

a)

Myocarditis

b)

Atherosclerosis

c)

Pericarditis

d)

Congenital coronary anomalies

11.

Which description correctly characterizes atherosclerosis in CAD?

a)

Rapid-onset disease that resolves spontaneously within weeks

b)

Slow, progressive disease that begins in childhood and takes decades to advance

c)

Acute inflammatory process limited to the myocardium

d)

Degenerative valve disease unrelated to the endothelium

12.

Plaque formation in coronary arteries is described as the build-up of lipids (cholesterol) forming as a response to which initiating event?

a)

Injury to the endothelium in the artery wall

b)

Loss of myocardial contractility

c)

Vagal stimulation of the heart

d)

Destruction of cardiac valves

13.

Which statement differentiates stable angina from unstable angina in the context of ischemic heart disease?

a)

Stable angina has increased frequency at rest and high MI risk; unstable angina is relieved by rest

b)

Stable angina is a chronic pattern precipitated by exertion or emotional upset and relieved by rest; unstable angina is part of acute coronary syndrome with increased frequency and duration, sometimes at rest

c)

Stable angina always shows ST elevation; unstable angina shows no ECG changes

d)

Stable angina causes myocardial necrosis; unstable angina never requires treatment

14.

Which feature is typical of stable angina episodes?

a)

ST segment elevation with permanent myocardial damage

b)

Temporary depression of the ST segment without permanent myocardial damage

c)

No ECG changes and prolonged necrosis

d)

Immediate thrombus formation in the coronary artery

15.

Acute Myocardial Infarction in CAD most commonly results from which mechanism?

a)

Coronary vasodilation during exercise

b)

Prolonged cessation of blood supply due to acute thrombus at the site of coronary atherosclerotic stenosis

c)

Increased oxygen delivery from collateral vessels

d)

Transient arrhythmia without ischemia

16.

Which intervention is listed under guideline management as primary and secondary prevention for coronary artery disease?

a)

Statins

b)

Calcium channel blockers

c)

Nitrates

d)

Antiplatelet agents

17.

A principal goal of therapy for ischemic heart disease is to decrease myocardial oxygen demand by reducing inotropic and chronotropic activity. Which strategy directly supports this goal?

a)

Increase venous return to the heart

b)

Maximize coronary vasodilatation

c)

Reduce force and rate of myocardial contraction

d)

Increase fibrin clot formation

18.

According to the nitrates/nitrite section, which side effect is commonly associated with nitrate use?

a)

Bradycardia

b)

Transient throbbing headache

c)

Hyperglycemia

d)

Constipation

19.

Which of the following is a beneficial effect of nitrates in the therapy of angina?

a)

Reflex tachycardia

b)

Increased myocardial oxygen requirement

c)

Vasodilation of epicardial coronary arteries relieving coronary artery spasm

d)

Decreased coronary perfusion

20.

Calcium channel blockers in angina primarily act to:

a)

Increase myocardial oxygen demand and decrease supply

b)

Decrease myocardial oxygen requirements and increase myocardial oxygen supply

c)

Increase systemic vascular resistance and blood pressure

d)

Stimulate beta-2 receptors to promote vasodilation

21.

Which statement best characterizes nifedipine among dihydropyridine CCBs?

a)

It is newer with slower and longer duration of action

b)

It can cause a fall in blood pressure with a trigger increase in heart rate and has been associated with increased MI frequency due to stealing phenomenon

c)

It is primarily used as a first-line agent before beta blockers and nitrates

d)

It increases left ventricular contractility

22.

Non-dihydropyridine CCBs (phenylalkylamine & benzothiazepine) in stable angina are typically:

a)

Primary agents used before beta blockers

b)

Secondary agents considered after beta blockers and nitrate therapy

c)

Contraindicated in left ventricular dysfunction

d)

Known to increase inotropic effects substantially

23.

Amlodipine compared with older dihydropyridines is:

a)

Associated with abrupt cessation tachycardia and MI

b)

Newer DHP with slower, longer duration and mildly decreased inotropic effects

c)

Known to increase mortality in advanced heart failure when added to ACE inhibitor, diuretic, and digoxin

d)

Short-acting with rapid onset causing reflex tachycardia

24.

Which beta blocker outcome is emphasized for patients after acute myocardial infarction?

a)

Increase vasospasm episodes

b)

Decrease mortality after myocardial infarction

c)

Increase myocardial oxygen demand by increasing heart rate

d)

Preferable in predominant coronary artery vasospasm

25.

In stable angina, symptomatic improvement and better outcomes have been observed with which therapy compared to calcium channel blockers?

a)

Long-acting nitrates

b)

Beta blockers

c)

Amlodipine

d)

Nicardipine

26.

Abrupt cessation of beta blockers may lead to which complication?

a)

Bradycardia and hypotension

b)

Tachycardia, angina, or myocardial infarction

c)

Hyperkalemia

d)

Pulmonary edema

27.

Which change in heart rate is typically seen with nitrates alone in angina pectoris therapy?

a)

Decrease

b)

Increase (reflex)

c)

No change

d)

Variable depending on dose

28.

In chronic stable angina, which combination is generally recommended as initial pharmacotherapy?

a)

Beta blocker plus long-acting nitrate or a calcium channel blocker (not verapamil)

b)

Verapamil alone

c)

Short-acting nitrate only

d)

Digoxin plus amiodarone

29.

Which statement best describes the effect of combined nitrates with β-blockers on arterial pressure in angina pectoris?

a)

Increase arterial pressure

b)

Decrease arterial pressure

c)

No change in arterial pressure

d)

Arterial pressure may increase or decrease

30.

Primary coronary vasospasm (Prinzmetal angina) should be treated with which of the following?

a)

Beta blockers

b)

Nitrates and calcium channel blockers

c)

Digoxin

d)

Amiodarone

31.

Which adverse effect is a potential complication associated with beta-blockers?

a)

Hyperreflexia

b)

Improved exercise tolerance

c)

Insomnia and unpleasant dreams

d)

Hyperglycemic ketoacidosis

32.

To minimize nitrate tachyphylaxis, which strategy aligns with guideline-based management?

a)

Continuous 24-hour dosing without breaks

b)

Use long-acting nitrates with a daily nitrate-free interval

c)

Combine nitrates with digoxin

d)

Avoid calcium channel blockers

33.

Patients with chronic heart failure requiring antianginal therapy should preferentially receive which regimen according to the guidance?

a)

Short-acting nitrates only

b)

Long-acting nitrates, adding amlodipine if additional therapy is needed

c)

Verapamil monotherapy

d)

High-dose β-blockers combined with verapamil

34.

Beta blockers should be combined very cautiously with which agents due to potential for excessive bradycardia or CHF in left ventricular dysfunction?

a)

Amlodipine

b)

Verapamil or diltiazem

c)

Nitrates

d)

Ivabradine

35.

Which statement best describes the mechanism of calcium channel blockers (CCBs) in angina treatment?

a)

They increase intracellular calcium in vascular smooth muscle to enhance contraction

b)

They block L-type calcium channels, reducing calcium influx and causing vasodilation

c)

They inhibit β1 receptors in the heart to reduce heart rate and contractility

d)

They increase nitric oxide production to dilate coronary arteries

36.

Dihydropyridine calcium channel blockers primarily exert which effect that benefits patients with angina?

a)

Negative chronotropy with marked heart-rate reduction

b)

Peripheral vasodilation leading to decreased afterload

c)

Direct inhibition of platelet aggregation

d)

Enhanced myocardial contractility

37.

Which agent class is most associated with bradycardia and atrioventricular (AV) block as potential adverse effects?

a)

Nitrates

b)

Dihydropyridine CCBs

c)

Non-dihydropyridine CCBs

d)

Thrombolytics

38.

Non-dihydropyridine CCBs (e.g., verapamil, diltiazem) are indicated in angina primarily for which therapeutic action?

a)

Reduction of myocardial oxygen demand via heart-rate and contractility suppression

b)

Increasing coronary perfusion by stimulating nitric oxide

c)

Enhancing platelet inhibition

d)

Promoting diuresis to lower preload

39.

Which statement accurately describes the mechanism of beta blockers in angina management?

a)

They antagonize β1 receptors, lowering heart rate and contractility to decrease oxygen demand

b)

They stimulate β2 receptors, causing coronary vasodilation

c)

They block calcium influx in vascular smooth muscle

d)

They release nitric oxide from endothelium

40.

Which is a typical contraindication to beta blocker use in angina?

a)

Essential hypertension

b)

Stable coronary artery disease without heart failure

c)

Severe asthma or bronchospasm

d)

Hyperlipidemia

41.

A patient with angina and resting bradycardia requires vasodilatory therapy without further heart-rate reduction. Which drug class is most appropriate?

a)

Non-dihydropyridine CCBs

b)

Beta blockers

c)

Dihydropyridine CCBs

d)

Class I antiarrhythmics

42.

In a patient with Prinzmetal (variant) angina, which class is preferred due to coronary vasodilation without negative inotropic effects?

a)

Beta blockers

b)

Dihydropyridine calcium channel blockers

c)

Non-dihydropyridine calcium channel blockers

d)

Nitrates only

43.

Which condition is an absolute contraindication to initiating a non-selective beta blocker in a patient with chronic stable angina?

a)

Controlled hypertension

b)

Severe asthma with active bronchospasm

c)

Type 2 diabetes mellitus managed with metformin

d)

Stable peripheral vascular disease

44.

A patient on long-acting nitrates develops reflex tachycardia. Which strategy leveraging beta blocker pharmacology best mitigates this effect without compromising myocardial oxygen supply?

a)

Add a short-acting dihydropyridine calcium channel blocker

b)

Increase nitrate dose to maximize venodilation

c)

Add a cardioselective beta-1 blocker to blunt sympathetic drive

d)

Switch to immediate-release nitrate formulations

45.

Which clinical scenario warrants caution or dose adjustment when prescribing beta blockers due to potential masking of hypoglycemia?

a)

Elderly patient with osteoarthritis

b)

Patient with insulin-treated diabetes

c)

Patient with mild allergic rhinitis

d)

Athlete with patellar tendinopathy

46.

In constructing a drug selection plan for chronic stable angina, which sequence reflects evidence-based first-line therapy and escalation?

a)

Start with nitrates; if symptoms persist, add ranolazine; then consider beta blocker

b)

Begin with beta blocker; add long-acting nitrate if angina persists; consider calcium channel blocker if still symptomatic

c)

Initiate calcium supplements; add aspirin; consider proton pump inhibitor

d)

Start with ivabradine in all patients; add loop diuretic if needed

47.

Which beta blocker property is most appropriate for a patient with angina and moderate chronic obstructive pulmonary disease (COPD)?

a)

Intrinsic sympathomimetic activity to maintain heart rate

b)

Non-selective beta blockade to reduce peripheral resistance

c)

Cardioselective beta-1 blockade to minimize bronchial beta-2 inhibition

d)

Combined alpha and beta blockade to enhance vasodilation

48.

Concurrent use of nitrates with beta blockers provides what net hemodynamic benefit in chronic stable angina management?

a)

Increases preload and heart rate

b)

Reduces myocardial oxygen demand via decreased heart rate and preload

c)

Elevates afterload to improve coronary perfusion

d)

Primarily increases contractility

49.

Which antiplatelet drug is an irreversible cyclooxygenase-1 (COX-1) inhibitor that reduces thromboxane A2–mediated platelet aggregation?

a)

Aspirin

b)

Clopidogrel

c)

Ticagrelor

d)

Prasugrel

50.

Clopidogrel and prasugrel are classified as which type of antiplatelet agents?

a)

Direct thrombin inhibitors

b)

P2Y12 receptor antagonists (thienopyridines)

c)

GPIIb/IIIa inhibitors

d)

Factor Xa inhibitors

51.

Which P2Y12 inhibitor is reversible and not a thienopyridine, offering faster onset and offset of platelet inhibition?

a)

Aspirin

b)

Clopidogrel

c)

Ticagrelor

d)

Prasugrel

52.

For patients with coronary heart disease (CHD), what is the typical target for low-density lipoprotein cholesterol (LDL-C) when using diet and drug therapy?

a)

LDL-C < 160 mg/dL

b)

LDL-C < 130 mg/dL

c)

LDL-C < 100 mg/dL (or < 70 mg/dL in very high risk)

d)

LDL-C < 50 mg/dL for all

53.

Which statement best describes the Healthy Heart Diet recommended for CHD patients?

a)

High saturated fat, low fiber, and increased sodium

b)

Emphasizes fruits, vegetables, whole grains, lean proteins, and limited saturated/trans fats

c)

Ketogenic diet with minimal carbohydrates

d)

High-protein, low-fat diet with unrestricted sugar

54.

Therapeutic Lifestyle Change (TLC) diet most directly aims to reduce which lipid parameter through reduced saturated fat and cholesterol intake plus plant stanols/sterols?

a)

HDL-C

b)

Triglycerides

c)

LDL-C

d)

Lipoprotein(a)

55.

Which drug class is first-line for lowering LDL-C and reducing cardiovascular events in CHD?

a)

Bile acid sequestrants

b)

Nicotinic acid (niacin)

c)

Statins (HMG-CoA reductase inhibitors)

d)

Omega-3 fatty acids

56.

Which lipid-lowering therapy works by binding bile acids in the intestine to increase fecal excretion and upregulate LDL receptors?

a)

Statins

b)

Bile acid sequestrants

c)

Nicotinic acid

d)

PCSK9 inhibitors

57.

Which statement best defines Acute Coronary Syndrome (ACS) in the context of cardiovascular emergencies?

a)

A group of conditions resulting from decreased coronary blood flow causing acute myocardial ischemia

b)

A chronic valve disease leading to heart failure over years

c)

An arrhythmic disorder characterized by abnormal electrical conduction without ischemia

d)

A congenital malformation of the coronary arteries detected in infancy

58.

Which topic is most central to the introductory discussion of ACS in this section?

a)

Electrolyte abnormalities in renal failure

b)

Overview of ACS and coronary artery anatomy

c)

Pulmonary embolism diagnostics

d)

Chronic heart failure medication titration

59.

Why is ACS considered life-threatening in emergency care?

a)

It rarely causes symptoms

b)

It is associated with significant mortality if not rapidly diagnosed and treated

c)

It only affects peripheral circulation

d)

It is self-limited and resolves without intervention

60.

Which anatomical focus is introduced alongside ACS to support clinical understanding?

a)

Cerebral arterial circle of Willis

b)

Coronary artery anatomy

c)

Pulmonary arterial tree

d)

Renal microvasculature

61.

Which statement about mortality in ACS aligns with the section’s emphasis?

a)

Mortality from ACS is negligible with any care

b)

ACS has notable mortality rates, underscoring urgent management

c)

Mortality is solely due to congenital coronary anomalies

d)

Mortality is primarily from non-cardiac chest pain

62.

Which anti-ischemic medication is recommended as a sublingual agent in the initial management step for suspected ACS with ST-segment elevation?

a)

Nitroglycerin (IV infusion)

b)

Isosorbide dinitrate (ISDN) 5 mg sublingual

c)

Beta-blocker oral

d)

Ranolazine

63.

In the antiplatelet component of initial ACS management, which regimen is specified?

a)

Aspirin 75 mg enteric-coated swallowed whole

b)

Aspirin 160 mg chewed and non–enteric-coated; plus clopidogrel 300 mg or ticagrelor 180 mg

c)

Clopidogrel 75 mg alone

d)

Ticagrelor 90 mg twice daily only

64.

According to the reperfusion strategy flow, what is the preferred approach for a STEMI diagnosis in a primary PCI–capable center when timely PCI is available?

a)

Immediate fibrinolysis

b)

Primary PCI

c)

Delayed coronary angiography after 24 hours

d)

Rescue PCI only if shock develops

65.

Which pairing correctly categorizes reperfusion strategies as Mechanical versus Pharmacological?

a)

Mechanical: fibrinolytic; Pharmacological: primary PCI

b)

Mechanical: primary PCI; Pharmacological: fibrinolytic

c)

Mechanical: coronary angiography; Pharmacological: PCI

d)

Mechanical: aspirin loading; Pharmacological: stent placement

66.

For a STEMI patient in a non–PCI-capable hospital presenting early (<3 hours) without contraindications, what reperfusion strategy is indicated?

a)

Primary PCI at the same hospital

b)

Immediate fibrinolytic therapy

c)

Observation and repeat ECG only

d)

Transfer for elective angiography after 12 hours

67.

Which scenario favors primary PCI according to the strategy summary?

a)

Non–PCI-capable hospital with onset >12 hours

b)

Primary PCI–capable hospital with 24-hour cath lab service and within 12 hours of symptom onset or when fibrinolytic is contraindicated

c)

Any hospital beyond 24 hours from symptom onset

d)

Patient stabilized after fibrinolysis only

68.

Which of the following is listed as an absolute contraindication to fibrinolytic therapy?

a)

Remote ischemic stroke >1 year ago

b)

Active internal bleeding (not menses)

c)

Controlled hypertension with systolic 140 mmHg

d)

Age >75 years

69.

After fibrinolytic therapy, which next-step interventions are included in the reperfusion strategy?

a)

No further interventions

b)

Coronary angiography and PCI

c)

Beta-blocker infusion only

d)

Repeat fibrinolysis within 1 hour

70.

Which reperfusion strategy is categorized as a mechanical intervention for STEMI management?

a)

Streptokinase

b)

Alteplase

c)

Primary PCI with balloon/stent

d)

Fibrinolysis

71.

In the context of fibrinolytic therapy, which agent listed is a thrombolytic used in ACS?

a)

Balloon

b)

Stent

c)

Streptokinase

d)

Contrast dye

72.

During initial evaluation for suspected UA/NSTEMI, biomarkers that are positive most likely indicate which diagnosis?

a)

Unstable angina (UA)

b)

NSTEMI

c)

STEMI has already ruled out

d)

Pericarditis

73.

Which statement best distinguishes UA from NSTEMI in the initial evaluation pathway shown?

a)

UA presents with ST elevation on ECG

b)

NSTEMI has negative cardiac biomarkers

c)

UA has positive cardiac biomarkers

d)

Both lack ST elevation, but UA has negative biomarkers while NSTEMI has positive biomarkers

74.

Which clinical presentation belongs to the angina spectrum highlighted under Clinical Diagnosis?

a)

Angina first onset

b)

Ventricular fibrillation

c)

Aortic dissection

d)

Pericardial knock

75.

For a patient with real STEMI case imaging, what reperfusion approach is emphasized as the primary strategy?

a)

Primary PCI

b)

Observation only

c)

Negative biomarkers indicate UA

d)

Beta-blockers alone

76.

Which pair correctly matches intervention type to category as depicted: balloon/stent vs. streptokinase/alteplase?

a)

Both are diagnostic tests

b)

Balloon/stent are fibrinolytics; streptokinase/alteplase are mechanical

c)

Balloon/stent are mechanical (PCI); streptokinase/alteplase are fibrinolytics

d)

Neither is used in ACS

77.

Which combination best represents the ONIMASE protocol elements for initial relief in suspected STEMI?

a)

Oxygen, Nitrates, Morphine, Aspirin

b)

Oxygen, Naloxone, Metoprolol, Atropine

c)

Ondansetron, Nitroglycerin, Midazolam, Amiodarone

d)

Oxygen, Nifedipine, Morphine, Alteplase

e)

Omeprazole, Nitrites, Magnesium, Aspirin

78.

For immediate nitrate therapy in suspected STEMI, which dosing schedule is specified?

a)

0.4 mg SL once

b)

5 mg SL three times at 5-minute intervals

c)

2 mg IV bolus once

d)

10 mg SL every hour

e)

Transdermal patch 5 mg daily

79.

According to the initial treatment guidance, what is the recommended aspirin administration?

a)

Enteric-coated aspirin 81 mg swallowed

b)

Chewed aspirin 160 mg, non enteric-coated

c)

Aspirin 325 mg IV infusion

d)

Aspirin 500 mg rectal suppository

e)

Aspirin 75 mg chewed, enteric-coated

80.

Which step is included in Step 2: Diagnosis Validation and Risk Assessment for acute chest pain?

a)

Immediate thrombolysis for all patients

b)

Serial ECG evaluation

c)

Routine CT angiography

d)

Discontinue all antiplatelets

e)

Start long-term beta-blocker therapy

81.

In Step 2, which cardiac biomarker approach is highlighted for rapid rule-out?

a)

CK-MB at presentation only

b)

Troponin measured only after 6–9 hours

c)

High-sensitivity troponin (Hs–Troponin)

d)

Myoglobin within 24 hours

e)

BNP at presentation and discharge

82.

In the rapid rule-out pathway using Hs–Troponin for acute chest pain, what does no change in serial Hs–Tn with values below the 99th percentile most directly support?

a)

Immediate cath lab activation for STEMI

b)

Discharge with appropriate follow-up

c)

Diagnosis of pericarditis

d)

Administration of thrombolytics

e)

Admission to ICU for heart failure

83.

Risk stratification includes assessing two parallel risks. Which pair is emphasized?

a)

Arrhythmia and infection

b)

Thrombosis and bleeding

c)

Hypertension and diabetes

d)

Stroke and renal failure

e)

Pulmonary embolism and DVT

84.

During initial management of suspected STEMI, which symptom group is specifically targeted for relief alongside pharmacologic measures?

a)

Fever, rash, and cough

b)

Breathlessness, pain, and anxiety

c)

Nausea, vomiting, and diarrhea

d)

Syncope, vertigo, and tremor

e)

Headache, vision loss, and tinnitus

85.

Which medication is listed under anti-ischemic therapy in ACS management?

a)

Nitrate

b)

Aspirin

c)

Clopidogrel

d)

Fondaparinux

86.

Which antiplatelet loading dose combination is correctly matched from the ACS management section?

a)

Aspirin 160 mg; Clopidogrel 300 mg or Ticagrelor 180 mg

b)

Aspirin 81 mg; Clopidogrel 75 mg or Ticagrelor 90 mg

c)

Aspirin 325 mg; Prasugrel 10 mg

d)

Aspirin 160 mg; Prasugrel 5 mg

87.

Which anticoagulant option listed is a low molecular weight heparin?

a)

UFH

b)

Enoxaparin

c)

Aspirin

d)

Ticagrelor

88.

In the invasive strategy table, which risk category corresponds to GRACE risk score >140 and indicates an early invasive evaluation?

a)

Low risk

b)

Intermediate risk

c)

High risk

d)

No risk

89.

According to the management flow, what is the recommended urgency for coronary angiography in high-risk ACS after validation?

a)

Urgent <120 min

b)

Early <24 h

c)

Within 72 h

d)

Nonselective with outpatient follow-up

90.

Which statement about STEMI management is correct based on the summary?

a)

PCI-capable hospital: perform PCI

b)

Non-PCI capable hospital: discharge patient

c)

Time to PCI >120 minutes: proceed to PCI locally

d)

After fibrinolytic therapy: no further angiography is needed

91.

Which diagnostic finding defines STEMI in the summary section on acute chest pain diagnosis?

a)

ECG: persistent ST elevation

b)

Biomarkers: negative troponin

c)

ECG: T-wave inversion only

d)

Biomarkers: normal CK-MB

92.

For UA/NSTEMI in the summary, which step is emphasized for high-risk patients?

a)

Fibrinolytic therapy immediately

b)

Invasive strategy

c)

No biomarker testing

d)

Routine discharge

93.

Which intervention is the definitive reperfusion strategy for STEMI when available within guideline timeframes?

a)

Primary PCI

b)

Coronary artery bypass grafting (CABG)

c)

Beta-blocker therapy alone

d)

Heparin infusion alone

94.

During primary PCI, which device is deployed to scaffold the coronary artery after balloon dilation?

a)

Pacemaker lead

b)

Stent

c)

Intravascular ultrasound catheter

d)

Thrombus aspiration cannula

95.

Which fibrinolytic agent is classified as a tissue plasminogen activator (tPA) used in STEMI reperfusion when PCI is not immediately available?

a)

Streptokinase

b)

Alteplase

c)

Warfarin

d)

Clopidogrel

96.

A patient presents with severe central chest pain and the ECG shows persistent ST elevation with reciprocal changes. What diagnosis is most consistent with this presentation?

a)

Unstable angina

b)

NSTEMI

c)

STEMI

d)

Pericarditis

97.

In the initial evaluation of suspected UA/NSTEMI, which combination best guides diagnosis when ST elevation is absent?

a)

Symptoms and chest X‑ray

b)

ST changes without elevation and cardiac biomarkers

c)

Echocardiography alone

d)

Blood pressure trend only

98.

A 70‑year‑old with severe chest pain has an ECG without ST elevation but elevated troponin. Which management pathway is most appropriate?

a)

Treat as STEMI with immediate fibrinolysis

b)

Classify as NSTEMI and proceed with anti‑ischemic, antithrombotic therapy and early invasive evaluation

c)

Discharge home with reassurance

d)

Delay treatment until pain resolves

99.

Which statement correctly differentiates UA from NSTEMI in the initial assessment?

a)

UA has elevated troponin while NSTEMI does not

b)

Both show ST elevation on ECG

c)

UA lacks biomarker elevation whereas NSTEMI shows positive cardiac biomarkers

d)

NSTEMI is defined only by chest pain duration

100.

Which component is correctly associated with UA/NSTEMI initial treatment summarized by the mnemonic ONIMASE?

a)

Immediate thrombolysis in all cases

b)

Oxygen for hypoxemia, nitrates for pain relief, and aspirin for antiplatelet therapy

c)

Delay antiplatelet therapy until troponin is positive

d)

Strict bed rest without pharmacologic therapy

101.

High-sensitivity troponin (hs-Troponin) is primarily used in which diagnostic step for suspected ACS?

a)

Confirming heart failure etiology

b)

Rapid rule-out and validation of NSTEMI diagnosis

c)

Detecting pulmonary embolism exclusively

d)

Determining need for thrombolysis in STEMI

102.

Which scenario is most likely to produce a false-positive elevation of cardiac biomarkers?

a)

Acute plaque rupture with thrombosis

b)

Sepsis or renal failure causing non-ischemic myocardial injury

c)

Classic angina relieved by nitrates with normal biomarkers

d)

Confirmed STEMI with ST elevation and reciprocal changes

103.

In risk stratification for UA/NSTEMI, which pair correctly matches the focus domain?

a)

THROMBOSIS—risk of bleeding; BLEEDING—risk of ischemia

b)

THROMBOSIS—ischemic risk; BLEEDING—hemorrhagic risk

c)

THROMBOSIS—arrhythmia risk; BLEEDING—renal risk

d)

THROMBOSIS—infection risk; BLEEDING—stroke risk only

104.

A 48-year-old man presents with severe central chest pain for 1 hour. The ECG shows ST-segment depression with T-wave inversion in multiple leads. What is the most appropriate immediate action within the ONIMASE approach?

a)

Administer thrombolytics immediately

b)

Provide aspirin and nitrates, assess oxygen needs, and arrange troponin testing

c)

Withhold all antiplatelets until coronary angiography

d)

Discharge after pain relief

105.

An 80-year-old man with prior MI and angina presents with ongoing chest pain unresponsive to sublingual nitrates. ECG reveals diffuse ST depression with possible transient ST elevation in aVR. Which next step best aligns with diagnosis validation and risk assessment?

a)

Assume musculoskeletal pain and stop evaluation

b)

Initiate ONIMASE measures and obtain rapid hs-troponin for rule-out/rule-in

c)

Administer high-dose steroids for pericarditis

d)

Wait 24 hours before any testing

106.

According to the MI type schema, which description corresponds to MI Type 1?

a)

Supply–demand imbalance alone without atherothrombosis

b)

Vasospasm or endothelial dysfunction without plaque rupture

c)

Fixed atherosclerosis with supply–demand imbalance

d)

Plaque rupture with thrombosis

107.

Based on trends in NSTE-ACS, how does cumulative one-year mortality for NSTEMI compare to STEMI?

a)

NSTEMI consistently higher than STEMI throughout the year

b)

STEMI consistently higher than NSTEMI throughout the year

c)

NSTEMI initially higher, then lower than STEMI over time

d)

Similar by one year with early higher mortality in STEMI

108.

Hospital vs 1-year mortality comparisons show which pattern when contrasting STEMI and NSTEMI?

a)

NSTEMI has higher in-hospital mortality but lower 1-year mortality than STEMI

b)

STEMI has higher in-hospital mortality while NSTEMI shows higher 1-year mortality

c)

Both have identical hospital and 1-year mortality

d)

STEMI dominates both hospital and 1-year mortality

109.

Which therapy category in ACS management primarily aims to reduce myocardial oxygen demand and relieve ischemic symptoms?

a)

Antiplatelet therapy

b)

Anti-ischemic therapy

c)

Anticoagulant therapy

d)

Fibrinolytic therapy

110.

In the invasive strategy for ACS, which approach involves early coronary angiography with possible percutaneous coronary intervention (PCI) for high-risk patients?

a)

Conservative observation

b)

Delayed invasive approach after 72 hours

c)

Immediate invasive strategy

d)

Medical management only

111.

For STEMI diagnosis and initial management, what is the primary time-sensitive reperfusion method emphasized?

a)

Beta-blocker initiation

b)

Percutaneous coronary intervention (PCI)

c)

Long-term statin therapy

d)

Cardiac rehabilitation

112.

Which medication class is central to preventing thrombus propagation by inhibiting the coagulation cascade in ACS?

a)

Nitrates

b)

Anticoagulants

c)

Calcium channel blockers

d)

ACE inhibitors

113.

In UA/NSTEMI management, dual antiplatelet therapy (DAPT) typically combines aspirin with which additional agent?

a)

Warfarin

b)

Clopidogrel or another P2Y12 inhibitor

c)

Heparin

d)

Alteplase

114.

Which best differentiates UA/NSTEMI from STEMI on initial evaluation?

a)

Presence of ST-segment elevation on ECG

b)

Presence of cardiogenic shock

c)

Elevated blood pressure

d)

Normal troponins

115.

Anti-ischemic management in ACS commonly targets heart rate and preload/afterload. Which combination is most aligned with this goal?

a)

Beta-blockers and nitrates

b)

Aspirin and clopidogrel

c)

Heparin and fondaparinux

d)

Statins and ACE inhibitors

116.

Which summary statement aligns with evidence-based ACS care across presentations?

a)

Antiplatelets are optional if anticoagulants are used

b)

Early risk stratification guides an invasive strategy and the intensity of antithrombotic therapy

c)

Nitrates should be avoided in all ACS cases

d)

PCI is reserved only for STEMI

117.

A flow diagram shows obstruction of coronary blood supply leading to hypoxia, myocardial ischemia, myocardial infarction/cell damage, and cellular contents appearing in circulation with CK–CKMB–AST–LDH–Troponin increase. Which step immediately precedes the rise of cardiac biomarkers in blood?

a)

Myocardial ischemia

b)

Return to baseline of CK

c)

Cellular contents cleared by kidneys

d)

ECG normalization

118.

Which laboratory test panel is most specific for myocardial injury according to the material?

a)

CK alone

b)

AST and LDH

c)

Troponin I and Troponin T

d)

Myoglobin only

119.

Attention to lab examination includes which of the following best practices?

a)

Use hemolytic sera for faster results

b)

Avoid IM injection, never use hemolytic sera, store serum immediately if delayed

c)

Freeze whole blood for later analysis

d)

Centrifuge after 24 hours

120.

Cardiac enzyme studies are primarily ordered to determine whether the patient is having which condition?

a)

Arrhythmia

b)

Heart attack/MI or threatened unstable angina

c)

Pulmonary embolism

d)

Stroke

121.

Which statement about creatine kinase (CK) sensitivity/specificity for cardiac damage is correct?

a)

CK has high sensitivity and specificity for cardiac damage

b)

CK has low sensitivity and specificity for cardiac damage

c)

CK is specific to cardiac muscle only

d)

CK is unaffected by non-cardiac conditions

122.

Serum CK levels rise within 4–6 hours after myocardial injury, peak at 12–24 hours, and return to baseline within about three days. What is the most appropriate clinical use of a serum CK level based on this description?

a)

Predicting infarct size

b)

Screening at admission and 6–12 hours after admission

c)

Diagnosing stroke

d)

Monitoring chronic heart failure

123.

Which biomarker is more cardiac-specific than CK alone and can be used to detect early re-infarction when repeated every 8 hours?

a)

AST

b)

LDH

c)

CK-MB

d)

BNP

124.

According to the material, which troponin shows approximately 90% sensitivity for MI 8 hours after onset of symptoms with 95% specificity?

a)

Troponin C

b)

Troponin T

c)

Troponin I

d)

Myoglobin

125.

Order a troponin test when a patient has chest pain with signs of a heart attack, worsening angina without other signs of MI, or to evaluate other causes of heart injury. What rationale best supports this decision?

a)

Troponin is released when heart muscle is damaged

b)

Troponin measures kidney function

c)

Troponin identifies arrhythmias directly

d)

Troponin is unaffected by timing after symptoms

126.

Results of a troponin test: levels increase within 6 hours, almost all MI patients elevated at 12 hours, may remain high for 1–2 weeks. What is the recommended repeat testing schedule?

a)

Repeat once at 48 hours only

b)

Repeated two more times over the next 6 to 24 hours

c)

Daily for 30 days

d)

No repeat needed if first test normal

127.

Which condition is NOT listed as a non-MI cause of increased troponin levels?

a)

Pulmonary hypertension

b)

Coronary artery spasm

c)

Long-term kidney disease

d)

Bacterial endocarditis

128.

In the context of myocardial injury, troponin is described as the most sensitive and specific test, persisting in blood for 7–10 days. Which marker, because of its short duration, can suggest infarct extension if it rises again?

a)

CK-MB

b)

BNP

c)

LDH

d)

AST

129.

LDH rises within 12–24 hours after cardiac injury, peaks at 3 days, and becomes normal at 8–9 days. Which additional statement is correct regarding LDH isoenzymes?

a)

LDH1

b)

LDH1>LDH2 (flipped LDH) supports infarct myocardium

c)

LDH isoenzymes are not used in MI

d)

LDH must never be repeated

130.

Myoglobin can be detected as early as two hours after myocardial necrosis begins and has low cardiac specificity but high sensitivity. What is its most appropriate clinical role?

a)

Confirming MI by itself

b)

Ruling out MI if early level is normal

c)

Estimating infarct size

d)

Monitoring long-term heart failure

131.

A table summarizes biomarker timelines. Which marker typically returns to normal around 3 days?

a)

Total CPK

b)

Troponin I

c)

LDH

d)

Troponin T

132.

A graph depicts release of cardiac markers following AMI with different curves. Which marker demonstrates the longest persistence in blood, remaining elevated up to 7–10 days?

a)

CK-MB

b)

MLC

c)

Troponin (T/I)

d)

LDH

133.

Which statement about BNP is accurate based on the material?

a)

BNP is produced mainly in the cardiac atria

b)

BNP is an amino acid polypeptide secreted by ventricles in response to excessive heart muscle cell stretch

c)

BNP is a brain-derived hormone not related to the heart

d)

BNP is a lipid secreted by endothelial cells

134.

Which biomarker test measures the amount of BNP in blood to indicate how well the heart is working and increases when the heart has to work harder over a long period, such as in heart failure?

a)

Troponin I

b)

BNP test

c)

CK-MB fraction

d)

Myoglobin

135.

In emergency settings, normal levels of both BNP and NT-proBNP in blood primarily help with which clinical decision?

a)

Confirming acute myocardial infarction

b)

Ruling out acute heart failure

c)

Diagnosing renal failure

d)

Monitoring extension of cardiac events

136.

According to the provided normal values, which BNP level is considered positive for heart failure?

a)

< 50 pg/mL

b)

50–100 pg/mL

c)

100–500 pg/mL

d)

> 500 pg/mL

137.

When the EKG is normal, which protocol is recommended to identify acute myocardial infarction (AMI)?

a)

Obtain CK-MB only at 8 hours

b)

Obtain Troponin at 0, 8, and 16 hours; obtain CK-MB at 0, 8, and 16 hours

c)

Measure BNP at 0 and 24 hours

d)

Use myoglobin alone at 1 hour

138.

Which statement best describes Troponin as a cardiac marker in the context of AMI?

a)

It rises 1–2 hours and peaks at 4–6 hours with duration 1–2 days

b)

It is the primary cardiac marker, specific for cardiac events, and levels stay elevated for 7–14 days

c)

It is useful for monitoring cardiac event extension

d)

Troponin T >1.0 suggests chronic heart failure only

139.

Which marker is identified as the first cardiac marker to increase but has poor specificity, helping only if negative?

a)

CK-MB

b)

Myoglobin

c)

AST/SGOT

d)

BNP

140.

In the combined protocol for AMI evaluation, what are the reported test sensitivity and specificity at 8 hours?

a)

Sensitivity ≥70%; Specificity 60–70%

b)

Sensitivity ≥98%; Specificity 80–95%

c)

Sensitivity ≥90%; Specificity ≥99%

d)

Sensitivity 50%; Specificity 50%

141.

Which biomarker is most sensitive and specific for diagnosing myocardial infarction among CK/CK-MB, troponin (TnI/TnT), and myoglobin?

a)

Creatine kinase (CK)

b)

CK-MB

c)

Troponin (TnI/TnT)

d)

Myoglobin

142.

Which statement best describes CK and CK-MB in the laboratory diagnosis of myocardial infarction?

a)

They have very high sensitivity and specificity

b)

They are specific but not sensitive

c)

They have relatively low sensitivity and specificity compared with troponin

d)

They are no longer measurable in modern laboratories

143.

Which marker rises earliest after myocardial injury but lacks specificity, limiting its standalone diagnostic utility?

a)

Troponin T

b)

Troponin I

c)

CK-MB

d)

Myoglobin

144.

High-sensitivity cardiac troponin T (hs-cTnT) assays primarily improve which aspect of MI diagnosis?

a)

Specificity only

b)

Detection of very low troponin levels and overall diagnostic accuracy

c)

Measurement of CK isoforms

d)

Detection of myoglobin clearance

145.

Which combination at emergency department presentation can rule out acute myocardial infarction with a negative predictive value of 95–100%?

a)

Positive CK and positive troponin

b)

Negative troponin and negative copeptin

c)

Positive myoglobin and negative CK

d)

Negative CK-MB and positive copeptin

146.

In hs-cTnT testing, what is a key trade-off when sensitivity is increased?

a)

Decreased specificity

b)

Longer turnaround time

c)

Inability to measure low troponin

d)

Loss of prognostic value

147.

Which statement about serial hs-cTnT testing is most accurate?

a)

Serial testing is unnecessary if one value is negative

b)

Serial testing and clinical context become increasingly important for interpreting hs-cTnT results

c)

Serial testing should be replaced by CK-MB trends

d)

Serial testing is only useful in chronic kidney disease

148.

Which property of copeptin makes it a useful complementary marker with troponin in early MI evaluation?

a)

It peaks later than troponin

b)

Its kinetics mirror vasopressin and it is released very early during AMI onset

c)

It is unaffected by osmolality

d)

It is specific only to cardiac tissue

149.

Which patient scenario benefits most from hs-cTnT’s improved sensitivity?

a)

Symptoms began several days ago

b)

Short duration from symptom onset to admission

c)

Chronic stable angina without symptoms

d)

Electrolyte disorders only

150.

What is the principal limitation of relying solely on CK for MI diagnosis compared with troponin?

a)

CK clears too slowly to detect MI

b)

CK is not present in blood after MI

c)

CK has lower sensitivity and specificity for myocardial injury

d)

CK requires radioactive labeling